Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
1 Görünümler
• 07/14/23
0
0
gömmek
administrator
Aboneler
Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar